Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Pathol Res Pract ; 203(8): 567-74, 2007.
Article in English | MEDLINE | ID: mdl-17679024

ABSTRACT

Mucinous carcinoma of the colorectum is conventionally defined as carcinoma with an interstitial mucus component (MC) that occupies more than 50% of the tumor tissue. To examine the validity of this definition, we quantified the ratio between the area of MC and the total area of carcinoma (MC ratio) in 152 advanced colorectal carcinomas, and investigated whether MUC1, MUC2 and MUC5AC mucin expression, frequency of p53 overexpression, and peritumoral lymphocytic infiltration (PLI) of tumors differ in the MC ratio. Samples were classified into MC ratios of >50% (n=30), 10-50% (n=24), <10% (n=22), and 0% (n=76). Carcinomas with MC commonly possessed the MUC2+ phenotype (90.9-100%), and 76.6-83.3% possessed either the MUC2+/MUC5AC+/MUC1+ or the MUC2+/MUC5AC-/MUC1+ phenotype. Carcinoma without MC (MC ratio of 0%) was typically the MUC2- phenotype (89.5%). Frequencies of p53 overexpression of carcinomas with MC were significantly lower compared to those without MC (21-27% vs. 55%). PLI was observed in 0-4% of carcinomas with MC, but was observed in 17% of carcinomas without MC. These results indicate that colorectal carcinomas with MC can be grouped together as goblet cell type (MUC2+) carcinoma. These data also suggest that such carcinomas may have a common genetic background and alteration of immune responsiveness. Therefore, separately classifying carcinomas with an MC ratio of more than 50% as an independent histological type may be invalid, and re-evaluation of the histological classification of colorectal carcinoma may be required.


Subject(s)
Adenocarcinoma, Mucinous/classification , Colorectal Neoplasms/classification , Lymphocytes, Tumor-Infiltrating/immunology , Mucins/biosynthesis , Tumor Suppressor Protein p53/biosynthesis , Adenocarcinoma, Mucinous/immunology , Adenocarcinoma, Mucinous/metabolism , Biomarkers, Tumor/analysis , Colorectal Neoplasms/immunology , Colorectal Neoplasms/metabolism , Female , Humans , Immunohistochemistry , Male , Middle Aged , Phenotype
2.
Pathol Int ; 54(6): 401-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15144398

ABSTRACT

This study examined whether gastric pyloric gland-type mucin is expressed in serrated adenoma (SA) and in hyperplastic polyp (HP) of the colorectum, and whether cellular position-based gastric differentiation is observed in these lesions as previously hypothesized. Immunostaining was performed for MUC6 and alpha-linked GlcNAc residue (pyloric gland-type mucin markers), human gastric mucin (HGM; foveolar-type mucin marker) and Ki-67 (proliferating cell marker) for 31 SA, 22 HP, 21 traditional tubular adenoma (TA) and 20 hyperplastic nodule (HN). MUC6 showed varying expression in SA, 22/31 (71.0%); HP, 15/22 (68.2%); TA, 2/21 (9.5%); and HN, 0/20 (0%) with significantly higher frequencies in SA and HP compared to those in TA and HN. The alpha-linked GlcNAc residue was found only in SA (3/31, 9.7%) and in HP (2/22, 9.1%). In SA and HP, HGM was typically expressed in the entire crypt length, but some reduction in expression was shown in the basal crypt portion below the proliferative zone. MUC6 and alpha-linked GlcNAc residues were expressed in the basal crypt portion below or below and including proliferative zone. These data demonstrate that SA and HP show bidirectional gastric (foveolar and pyloric gland) differentiation with respect to mucin cellular phenotype and the potential for cellular position-based differentiation, which mimics the gastric antral mucosa.


Subject(s)
Adenoma/metabolism , Antigens, Neoplasm/metabolism , Cell Transformation, Neoplastic , Colonic Polyps/metabolism , Colorectal Neoplasms/metabolism , Adenoma/pathology , Colonic Polyps/pathology , Colorectal Neoplasms/pathology , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Humans , Hyperplasia , Mucin 5AC , Mucin-6 , Mucins/metabolism
3.
Gan To Kagaku Ryoho ; 30(5): 606-13, 2003 May.
Article in Japanese | MEDLINE | ID: mdl-12795090

ABSTRACT

Histopathologically and biologically, endocrine cell tumors in the gastrointestinal tract are divided into two groups: 1) carcinoid, a low-grade malignancy, and 2) endocrine cell carcinoma (synonymous with small cell carcinoma), a high-grade malignancy. Atypical carcinoid, which has increased histological atypia and proliferative activity, shows more aggressive biological behavior than classical carcinoid. As a rule, endocrine cell carcinoma should be resected surgically with dissection of lymph nodes and adjuvant therapy if needed, while carcinoid should be treated by endoscopic resection or localized resection without lymph node dissection. Classical carcinoid of more than 2.0 cm in size and atypical carcinoid should be treated more carefully because of the increased risk of vascular permeation or distant metastasis.


Subject(s)
Carcinoid Tumor/pathology , Carcinoid Tumor/surgery , Gastrointestinal Neoplasms/pathology , Gastrointestinal Neoplasms/surgery , Carcinoid Tumor/classification , Diagnosis, Differential , Gastrointestinal Neoplasms/classification , Humans , Lymph Node Excision , Lymphatic Metastasis , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...